Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Copper chalcogenide nanoparticles, particularly Cu<sub>2–<i>x</i></sub><i>E</i> (<i>E</i> = S, Se, Te; 0 ≤ <i>x</i> ≤ 1), have gained significant interest in recent years due to their distinct physical and chemical properties, making them highly versatile for a wide range of applications. Among these, copper selenide nanoparticles (CS NPs) have attracted special attention due to their remarkable characteristics, which can be tailored through various modification strategies, providing significant potential for the diagnosis and treatment of neurological diseases. This review summarizes emerging trends and explores future perspectives on the use of CS NPs for diagnosing and treating central nervous system diseases, including glioblastoma and neurodegenerative disorders.
Authors
- Ke Yang (ORCID: https://orcid.org/0000-0001-9144-3955)
- Shuyang Xie (ORCID: https://orcid.org/0000-0002-8090-2180)
- Zhen Li (ORCID: https://orcid.org/0000-0003-0333-7699)
- Hao Zhang (ORCID: https://orcid.org/0009-0009-9322-0048)
- Tingting Wang (ORCID: https://orcid.org/0000-0002-0278-385X)
- Hualong Liu
Institutions
- Soochow University (CN)
Publication Details
- Journal
- Nano Biomedicine and Engineering
- Published
- 2025-03-01
- DOI
- https://doi.org/10.26599/nbe.2025.9290117
- Citations
- 19
- Primary Topic
- Advanced Nanomaterials in Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 9.84
Funders
- National Natural Science Foundation of China
- Soochow University
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
- National Key Research and Development Program of China